Bionexus Gene Lab Stock Price Prediction
| BGLC Stock | USD 0.29 0.01 3.33% |
Oversold Vs Overbought
35
Oversold | Overbought |
Quarterly Earnings Growth (0.95) | Quarterly Revenue Growth (0.23) |
Using BioNexus Gene hype-based prediction, you can estimate the value of BioNexus Gene Lab from the perspective of BioNexus Gene response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in BioNexus Gene to buy its stock at a price that has no basis in reality. In that case, they are not buying BioNexus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
BioNexus Gene after-hype prediction price | USD 0.29 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BioNexus |
BioNexus Gene After-Hype Price Prediction Density Analysis
As far as predicting the price of BioNexus Gene at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BioNexus Gene or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of BioNexus Gene, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
BioNexus Gene Estimiated After-Hype Price Volatility
In the context of predicting BioNexus Gene's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BioNexus Gene's historical news coverage. BioNexus Gene's after-hype downside and upside margins for the prediction period are 0.01 and 3.77, respectively. We have considered BioNexus Gene's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
BioNexus Gene is out of control at this time. Analysis and calculation of next after-hype price of BioNexus Gene Lab is based on 3 months time horizon.
BioNexus Gene Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as BioNexus Gene is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioNexus Gene backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BioNexus Gene, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.59 | 3.48 | 0.01 | 0.20 | 3 Events / Month | 10 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.29 | 0.29 | 0.00 |
|
BioNexus Gene Hype Timeline
BioNexus Gene Lab is currently traded for 0.29. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.2. BioNexus is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at -0.59%. %. The volatility of related hype on BioNexus Gene is about 1041.26%, with the expected price after the next announcement by competition of 0.49. About 44.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.56. Some equities with similar Price to Book (P/B) outperform the market in the long run. BioNexus Gene Lab has Price/Earnings (P/E) ratio of 350.0. The entity recorded a loss per share of 0.06. The firm had not issued any dividends in recent years. BioNexus Gene had 1:12 split on the 20th of July 2023. Given the investment horizon of 90 days the next expected press release will be in about 3 days. Check out BioNexus Gene Basic Forecasting Models to cross-verify your projections.BioNexus Gene Related Hype Analysis
Having access to credible news sources related to BioNexus Gene's direct competition is more important than ever and may enhance your ability to predict BioNexus Gene's future price movements. Getting to know how BioNexus Gene's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BioNexus Gene may potentially react to the hype associated with one of its peers.
BioNexus Gene Additional Predictive Modules
Most predictive techniques to examine BioNexus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioNexus using various technical indicators. When you analyze BioNexus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About BioNexus Gene Predictive Indicators
The successful prediction of BioNexus Gene stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as BioNexus Gene Lab, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of BioNexus Gene based on analysis of BioNexus Gene hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to BioNexus Gene's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to BioNexus Gene's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 6.0E-5 | 7.02E-4 | 6.32E-4 | 6.64E-4 | Price To Sales Ratio | 27.3 | 15.03 | 0.86 | 0.82 |
Story Coverage note for BioNexus Gene
The number of cover stories for BioNexus Gene depends on current market conditions and BioNexus Gene's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BioNexus Gene is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BioNexus Gene's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
BioNexus Gene Short Properties
BioNexus Gene's future price predictability will typically decrease when BioNexus Gene's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of BioNexus Gene Lab often depends not only on the future outlook of the potential BioNexus Gene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioNexus Gene's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.9 M | |
| Cash And Short Term Investments | 5.9 M |
Complementary Tools for BioNexus Stock analysis
When running BioNexus Gene's price analysis, check to measure BioNexus Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNexus Gene is operating at the current time. Most of BioNexus Gene's value examination focuses on studying past and present price action to predict the probability of BioNexus Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNexus Gene's price. Additionally, you may evaluate how the addition of BioNexus Gene to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |